Hospital
Providence ST Joseph Medical Center
Providence ST Joseph Medical Center was paid $652K by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.
33Billing provider infoPROVIDENCE ST JOSEPH MEDICAL CENTER
POLSON, MT 59860
POLSON, MT 59860
33aNPI1821184888assigned 10/05/2006
33bProvider typeCritical Access Hospital
28Total paid$652K
24GClaims227,079
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Montana
Rank by total paid#8 of 25
Median peer was paid$185K
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,653 | $71K | |
| 2019 | 34,099 | $120K | |
| 2020 | 29,080 | $78K | |
| 2021 | 38,159 | $100K | |
| 2022 | 34,484 | $123K | |
| 2023 | 29,386 | $69K | |
| 2024incomplete | 22,218 | $92K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 8,078 | 6,737 | $96K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 5,386 | 4,031 | $76K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 7,162 | 5,707 | $69K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.9% | 1,410 | 1,285 | $65K |
| 87631 | 4.6% | 2,122 | 2,022 | $30K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.6% | 6,673 | 1,903 | $24K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.5% | 1,746 | 1,664 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 1,391 | 1,248 | $21K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.8% | 1,107 | 1,047 | $18K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.0% | 2,149 | 1,035 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,733 | 1,661 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 4,710 | 4,060 | $12K |
136 more codes
| 80053 | Comprehensive metabolic panel | 1.7% | 16,259 | $11K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 1,670 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 3,165 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 3,064 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.3% | 554 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 16,016 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 2,646 | $7K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 978 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,487 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,649 | $6K |
| 80306 | <1% | 1,503 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,205 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,853 | $4K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 200 | $4K |
| 87081 | <1% | 2,661 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,786 | $3K |
| 81001 | <1% | 4,570 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,055 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,053 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,388 | $3K |
| 73110 | <1% | 507 | $3K | |
| 81025 | <1% | 2,932 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,443 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 99 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 439 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,439 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,275 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,071 | $2K |
| 87420 | <1% | 527 | $2K | |
| 83690 | <1% | 2,778 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,623 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 237 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,065 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,885 | $2K |
| 73630 | <1% | 666 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,319 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,592 | $2K |
| 73610 | <1% | 726 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,373 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,200 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,352 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 334 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,573 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,293 | $1K |
| 80061 | Lipid panel | <1% | 2,607 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,434 | $1K |
| 85027 | <1% | 3,383 | $951.53 | |
| 87077 | <1% | 2,041 | $896.62 | |
| 87186 | <1% | 1,704 | $874.07 | |
| 82077 | <1% | 1,127 | $812.94 | |
| 81003 | <1% | 2,315 | $810.83 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,652 | $799.15 |
| 87070 | <1% | 736 | $773.10 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,157 | $766.29 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 348 | $762.79 |
| 86140 | <1% | 1,458 | $691.96 | |
| 83605 | <1% | 1,051 | $685.98 | |
| 73030 | <1% | 339 | $666.60 | |
| 73130 | <1% | 384 | $630.27 | |
| 87040 | <1% | 629 | $628.57 | |
| 82728 | <1% | 457 | $616.96 | |
| 84484 | <1% | 2,280 | $609.14 | |
| 80305 | <1% | 458 | $605.95 | |
| 81002 | <1% | 3,663 | $582.72 | |
| 85652 | <1% | 873 | $480.98 | |
| 96376 | <1% | 342 | $423.59 | |
| 84703 | <1% | 699 | $422.44 | |
| 97161 | <1% | 175 | $422.00 | |
| 84439 | <1% | 1,006 | $387.55 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 637 | $361.94 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,609 | $352.36 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 38 | $316.78 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 736 | $301.17 |
| 85651 | <1% | 747 | $295.61 | |
| 73562 | <1% | 156 | $277.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 414 | $231.33 |
| 84145 | <1% | 129 | $205.50 | |
| 84702 | <1% | 271 | $200.69 | |
| 85610 | <1% | 2,051 | $194.93 | |
| 86900 | <1% | 248 | $183.29 | |
| 97162 | <1% | 137 | $180.00 | |
| 87205 | <1% | 648 | $158.42 | |
| 80143 | <1% | 158 | $150.83 | |
| 80179 | <1% | 146 | $141.65 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 139 | $138.00 |
| 86901 | <1% | 235 | $137.46 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 26 | $136.34 |
| 83550 | <1% | 86 | $132.16 | |
| 83880 | <1% | 140 | $127.79 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 924 | $120.30 |
| 85018 | <1% | 230 | $117.25 | |
| 87210 | <1% | 472 | $104.20 | |
| 83540 | <1% | 91 | $97.76 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 35 | $74.16 |
| 82962 | <1% | 1,340 | $64.66 | |
| 86803 | <1% | 791 | $62.70 | |
| 73080 | <1% | 27 | $61.24 | |
| 73560 | <1% | 44 | $52.53 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 44 | $51.25 |
| 87147 | <1% | 13 | $38.94 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 418 | $30.38 |
| 83735 | <1% | 568 | $29.46 | |
| 82607 | <1% | 31 | $28.50 | |
| 82805 | <1% | 42 | $11.72 | |
| A9270 | Non-covered item or service | <1% | 529 | $2.21 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 305 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 298 | $0.00 |
| 86850 | 0% | 88 | $0.00 | |
| 87430 | 0% | 13 | $0.00 | |
| 87340 | 0% | 65 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 23 | $0.00 |
| 73502 | 0% | 13 | $0.00 | |
| 84478 | 0% | 25 | $0.00 | |
| 86762 | 0% | 13 | $0.00 | |
| 85379 | 0% | 14 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 65 | $0.00 |
| 76830 | Ultrasound, transvaginal | 0% | 14 | $0.00 |
| 86592 | 0% | 27 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 14 | $0.00 |
| 80055 | 0% | 14 | $0.00 | |
| 88342 | 0% | 18 | $0.00 | |
| 82043 | 0% | 13 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 18 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 15 | $0.00 |
| 87806 | 0% | 84 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 361 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 124 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 176 | $0.00 |
| 82570 | 0% | 102 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 18 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 88 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 149 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 27 | $0.00 |
| 87653 | 0% | 13 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 12 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS)
Parent organizationPROVIDENCE HEALTH & SERVICES
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.